Question 1

What is the catalog number for COLGALT2 Antibody?

Accepted Answer

The catalog number for COLGALT2 Antibody is MBS969041.

Question 2

What sizes are available for COLGALT2 Antibody?

Accepted Answer

COLGALT2 Antibody is available in the following size(s): 0.05 mg, 0.1 mg, 5x 0.1 mg.

Question 3

How many pack sizes does COLGALT2 Antibody come in?

Accepted Answer

COLGALT2 Antibody is available in 3 different pack sizes.

Question 4

Is COLGALT2 Antibody in stock?

Accepted Answer

COLGALT2 Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

COLGALT2 Antibody

Product Specifications

CAS Number

Gene Name

NCBI Gene ID

Reactivity

Storage Conditions

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

NCBI GB Accession Number

Uniprot Accession Number

Available Sizes

Frequently Asked Questions

Explore Other Products

Tissue FFPE Sections, Colon: right

Nup53 (NUP35) (NM_001287585) Human Tagged ORF Clone

Ethyl 2-[Bis(2,2,2-trifluoroethyl)phosphono] Propionate

CD1a (O10 + C1A/711), CF640R conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), 0.2mg/mL

2,6-Deoxyfructosazine-13C4